Trustees Of Boston University

Trustees of Boston University, doing business as Boston University Medical Campus, is a prominent private research institution and tax-exempt nonprofit organization that serves as a child entity within the larger Boston University structure. The organization is registered in SAM.gov and maintains active federal contracting and grant capabilities across multiple scientific and medical disciplines. Boston University Medical Campus specializes in advanced biomedical research, clinical studies, and technical scientific services delivered to federal agencies including the National Institutes of Health, Department of Veterans Affairs, Department of Defense, and other civilian and military health research programs.

Through federal contract vehicles, Boston University Medical Campus has demonstrated substantial expertise in delivering research services, specialized technical support, and scientific consultation across multiple domains. The organization holds and executes delivery orders under indefinite delivery contracts with the Veterans Integrated Service Network 1 (VISN 1), with a major $27.1 million IDC spanning through August 2030 covering research services in neuroscience, infectious disease, public health, and biomedical engineering. Recent contract deliverables have included refinement education services, neuroimaging research support, PEPREC Research Services valued at $4.6 million, and research support services ranging from $74,951 to $648,547 per task order. The organization has also received firm fixed-price purchase orders from the National Cancer Institute for RNA sequencing and data processing services, and holds delivery orders under the National Heart Lung and Blood Institute for the Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells (BHIPSC-Lung) project valued at $3.75 million through May 2030. All identified contract awards utilize firm fixed-price or cost-no-fee pricing structures with no set-aside designations, reflecting Boston University's established status as a qualified contractor for complex federal research initiatives.

As a premier federal grant recipient, Boston University Medical Campus has secured substantial project grant funding from across the NIH portfolio and other federal health agencies, demonstrating leadership in translational and basic biomedical research. Recent grant awards include $1.478 million from the National Institute on Drug Abuse for buprenorphine treatment retention optimization, $1.742 million from the National Institute on Alcohol Abuse and Alcoholism for alcohol policy and health services research, and $848,993 from the National Institute on Aging examining tRNA modifications in Alzheimer's disease. The institution has received significant multi-year funding for Alzheimer's disease and related dementias research, including grants investigating digital biomarkers for cognitive decline, the role of environmental toxicants in neurodegeneration, and chronic traumatic encephalopathy pathology. Additional grant support spans vaccine response determinants from the National Institute of Allergy and Infectious Diseases ($176,738), cardiovascular disease research from the National Heart Lung and Blood Institute (multiple awards totaling over $3 million), and mental health interventions from the National Institute of Mental Health ($567,000-$1.466 million awards). The organization also manages training grants, including a $426,360 award for biomolecular pharmacology training and a $233,180 award supporting the Medical Scientist Training Program. Federal grant partners include the National Institute on Aging, NHLBI, NIAID, NCI, NIDDK, NINDS, and multiple NIH offices, with numerous sub-awards to leading research institutions including UC Davis, UCLA, University of Pennsylvania, Columbia University, and international partners in Malawi and other resource-limited settings.

Boston University Medical Campus maintains three active indefinite delivery contracts that provide ongoing research infrastructure and flexible task order issuance for federal agency partners. The primary contract is the $27.1 million single-award IDC with Veterans Integrated Service Network 1 (VISN 1), effective through August 31, 2030, providing research services across neuroscience, infectious disease, public health, and biomedical engineering with Roxbury, Massachusetts as the place of performance. The organization also holds a $3.75 million single-award IDC with the National Heart Lung and Blood Institute for the BHIPSC-Lung biorepository core administrative and scientific project tasks, extending through May 1, 2030. A third IDC valued at $92,028 with VISN 1 covers refinement education services with a last order date of January 4, 2029. These indefinite delivery vehicles enable Boston University Medical Campus to respond efficiently to evolving federal research priorities while maintaining ongoing partnership relationships with major health research agencies, allowing for rapid deployment of resources across multiple task orders without requiring individual full and open competition for each research initiative.